GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (STU:9OM1) » Definitions » Change In Payables And Accrued Expense

EXMceuticals (STU:9OM1) Change In Payables And Accrued Expense : €0.96 Mil (TTM As of Mar. 2021)


View and export this data going back to 2019. Start your Free Trial

What is EXMceuticals Change In Payables And Accrued Expense?

EXMceuticals's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2021 was €-0.06 Mil. It means EXMceuticals's Accounts Payable & Accrued Expense declined by €0.06 Mil from Dec. 2020 to Mar. 2021 .

EXMceuticals's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2020 was €1.40 Mil. It means EXMceuticals's Accounts Payable & Accrued Expense increased by €1.40 Mil from Jun. 2019 to Jun. 2020 .


EXMceuticals Change In Payables And Accrued Expense Historical Data

The historical data trend for EXMceuticals's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Change In Payables And Accrued Expense Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.06 0.06 0.14 1.40

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 0.82 0.03 0.17 -0.06

EXMceuticals Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EXMceuticals Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (STU:9OM1) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (STU:9OM1) Headlines

No Headlines